HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Dodé Selected Research

Kallmann Syndrome (Kallmann's Syndrome)

1/2017Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.
9/2015Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.
8/2014Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
8/2012SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.
10/2010Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions.
1/2010Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
1/2009PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
7/2008Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
1/2007Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis.
10/2006Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Dodé Research Topics

Disease

12Kallmann Syndrome (Kallmann's Syndrome)
01/2017 - 11/2004
12Hypogonadism (Hypergonadotropic Hypogonadism)
01/2017 - 08/2004
7Anosmia
01/2017 - 01/2005
2Cryptorchidism (Undescended Testes)
10/2011 - 01/2010
2Penis agenesis
10/2011 - 01/2010
2Inflammation (Inflammations)
02/2005 - 07/2002
2Fever (Fevers)
10/2004 - 07/2002
2Necrosis
10/2004 - 07/2002
1CHARGE Syndrome
10/2014
1Inborn Genetic Diseases (Disease, Hereditary)
09/2013
1Infertility (Sterility)
10/2011
1Sciatica (Sciatic Neuralgia)
09/2007
1Atrophy
06/2007
1Psychotic Disorders (Schizoaffective Disorder)
06/2007
1Tremor (Tremors)
06/2007
1Alcoholism (Alcohol Abuse)
06/2007
1Hereditary Autoinflammatory Diseases
02/2005
1Acute-Phase Reaction
02/2005
1Cryopyrin-Associated Periodic Syndromes
10/2004
1Urticaria (Hives)
10/2004
1Mevalonate Kinase Deficiency
10/2004
1Familial Mediterranean Fever (Periodic Disease)
07/2002
1Amyloidosis
07/2002

Drug/Important Bio-Agent (IBA)

11Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2017 - 08/2004
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2014 - 07/2008
2AA amyloidosisIBA
02/2005 - 07/2002
1Semaphorins (Semaphorin)IBA
01/2017
1Hormones (Hormone)IBA
09/2015
1Codon (Codons)IBA
10/2014
1Nonsense Codon (Nonsense Mutation)IBA
10/2014
1OligonucleotidesIBA
09/2013
1Semaphorin-3AIBA
08/2012
1GonadotropinsIBA
10/2011
1Follicle Stimulating Hormone (Follitropin)FDA Link
10/2011
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
10/2011
1Pituitary GonadotropinsIBA
10/2011
1Testosterone (Sustanon)FDA Link
01/2010
1Peptides (Polypeptides)IBA
01/2010
1LigandsIBA
07/2008
1Etanercept (Enbrel)FDA Link
09/2007
1Pharmaceutical PreparationsIBA
06/2007
1Protein Isoforms (Isoforms)IBA
01/2007
1AndrogensIBA
06/2005
1Blood Proteins (Serum Proteins)IBA
02/2005
1Proteins (Proteins, Gene)FDA Link
02/2005
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2004
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2004
1Type I Tumor Necrosis Factor ReceptorsIBA
07/2002

Therapy/Procedure

1Therapeutics
10/2011